A unique array of neuroprotective effects of pyruvate in neuropathology

Frontiers in Neuroscience

Volumn 9, Issue FEB, 2015, Pages

  Zilberter, Yuri ^a   Gubkina, Olena ^a   Ivanov, Anton I ^a  

^a AIX MARSEILLE UNIVERSITÉ   (France)

Author keywords

Energy metabolism; NAD; Neurodegeneration; Neuroinflammation; Oxidative stress; PARP 1; Pyruvate

Indexed keywords

GLUTAMIC ACID; GLYCOGEN; HYDROGEN PEROXIDE; LACTIC ACID; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PYRUVIC ACID;

ANTICONVULSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ASTROCYTE; CONCENTRATION (PARAMETERS); HUMAN; NEUROPATHOLOGY; NEUROPROTECTION; NOTE;

EID: 84949117192     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00017     Document Type: Note

References (40)

1. Abeti, R., Abramov, A. Y., and Duchen, M. R. (2011). Beta-amyloid activates PARP causing astrocytic metabolic failure and neuronal death. Brain 134, 1658-1672. doi: 10.1093/brain/awr104
2. Abeti, R., and Duchen, M. R. (2012). Activation of PARP by oxidative stress induced by beta-amyloid: implications for Alzheimer's disease. Neurochem. Res. 37, 2589-2596. doi: 10.1007/s11064-012-0895-x
3. Abramov, A. Y., and Duchen, M. R. (2005). The role of an astrocytic NADPH oxidase in the neurotoxicity of amyloid beta peptides. Philos. Trans. R. Soc. Lond. B Biol. Sci. 360, 2309-2314. doi: 10.1098/rstb.2005.1766
4. Alvarez, G., Ramos, M., Ruiz, F., Satrustegui, J., and Bogonez, E. (2003). Pyruvate protection against beta-amyloid-induced neuronal death: role of mitochondrial redox state. J. Neurosci. Res. 73, 260-269. doi: 10.1002/jnr.10648
5. Amatniek, J. C., Hauser, W. A., Delcastillo-Castaneda, C., Jacobs, D. M., Marder, K., Bell, K., et al. (2006). Incidence and predictors of seizures in patients with Alzheimer's disease. Epilepsia 47, 867-872. doi: 10.1111/j.1528-1167.2006.00554.x
6. Andrabi, S. A., Umanah, G. K., Chang, C., Stevens, D. A., Karuppagounder, S. S., Gagne, J. P., et al. (2014). Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis. Proc. Natl. Acad. Sci. U.S.A. 111, 10209-10214. doi: 10.1073/pnas.1405158111
7. Cai, H., Cong, W. N., Ji, S., Rothman, S., Maudsley, S., and Martin, B. (2012). Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disorders. Curr. Alzheimer Res. 9, 5-17. doi: 10.2174/156720512799015064
8. Carvalho, A. S., Torres, L. B., Persike, D. S., Fernandes, M. J., Amado, D., Naffah-Mazzacoratti Mda, G., et al. (2011). Neuroprotective effect of pyruvate and oxaloacetate during pilocarpine induced status epilepticus in rats. Neurochem. Int. 58, 385-390. doi: 10.1016/j.neuint.2010.12.014
9. Clark, R. S., Vagni, V. A., Nathaniel, P. D., Jenkins, L. W., Dixon, C. E., and Szabo, C. (2007). Local administration of the poly(ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice. J. Neurotrauma 24, 1399-1405. doi: 10.1089/neu.2007.0305
10. Das, U. N. (2006). Is pyruvate an endogenous anti-inflammatory molecule? Nutrition 22, 965-972. doi: 10.1016/j.nut.2006.05.009
11. Desagher, S., Glowinski, J., and Premont, J. (1997). Pyruvate protects neurons against hydrogen peroxide-induced toxicity. J. Neurosci. 17, 9060-9067.
12. Fukushima, M., Lee, S. M., Moro, N., Hovda, D. A., and Sutton, R. L. (2009). Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injury. J. Neurotrauma 26, 1095-1110. doi: 10.1089/neu.2008.0771
13. Gottlieb, M., Wang, Y., and Teichberg, V. I. (2003). Blood-mediated scavenging of cerebrospinal fluid glutamate. J. Neurochem. 87, 119-126. doi: 10.1046/j.1471-4159.2003.01972.x
14. Heneka, M. T., Kummer, M. P., and Latz, E. (2014). Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol. 14, 463-477. doi: 10.1038/nri3705
15. Holleman, A. F. (1904). Notice sur l'action de l'eau oxygénée sur les acides a-cétoniques et sur les dicétones 1. 2. Recueil des Travaux Chimiques des Pays-Bas et de la Belgique 23, 169-172. doi: 10.1002/recl.19040230504
16. Isopi, E., Granzotto, A., Corona, C., Bomba, M., Ciavardelli, D., Curcio, M., et al. (2014). Pyruvate prevents the development of age-dependent cognitive deficits in a mouse model of Alzheimer's disease without reducing amyloid and tau pathology. Neurobiol. Dis. doi: 10.1016/j.nbd.2014.11.013. [Epub ahead of print].
17. Kao, K. K., and Fink, M. P. (2010). The biochemical basis for the anti-inflammatory and cytoprotective actions of ethyl pyruvate and related compounds. Biochem. Pharmacol. 80, 151-159. doi: 10.1016/j.bcp.2010.03.007
18. Lee, J. Y., Kim, Y. H., and Koh, J. Y. (2001). Protection by pyruvate against transient forebrain ischemia in rats. J. Neurosci. 21:RC171.
19. Ma, Y., Chen, H., He, X., Nie, H., Hong, Y., Sheng, C., et al. (2012). NAD+ metabolism and NAD(+)-dependent enzymes: promising therapeutic targets for neurological diseases. Curr. Drug Targets 13, 222-229. doi: 10.2174/138945012799201711
20. Melo, A., Monteiro, L., Lima, R. M., Oliveira, D. M., Cerqueira, M. D., and El-Bacha, R. S. (2011). Oxidative stress in neurodegenerative diseases: mechanisms and therapeutic perspectives. Oxid. Med. Cell. Longev. 2011:467180. doi: 10.1155/2011/467180
21. Minkeviciene, R., Rheims, S., Dobszay, M. B., Zilberter, M., Hartikainen, J., Fülöp, L., et al. (2009). Fibrillar ß-amyloid-induced hyperexcitability of cortical and hippocampal neurons triggers progressive epilepsy. J. Neurosci. 29, 3453-3462. doi: 10.1523/JNEUROSCI.5215-08.2009
22. Mongan, P. D., Karaian, J., Van Der Schuur, B. M., Via, D. K., and Sharma, P. (2003). Pyruvate prevents poly-ADP ribose polymerase (PARP) activation, oxidative damage, and pyruvate dehydrogenase deactivation during hemorrhagic shock in swine. J. Surg. Res. 112, 180-188. doi: 10.1016/S0022-4804(03)00148-3
23. Moroni, F., and Chiarugi, A. (2009). Post-ischemic brain damage: targeting PARP-1 within the ischemic neurovascular units as a realistic avenue to stroke treatment. FEBS J. 276, 36-45. doi: 10.1111/j.1742-4658.2008.06768.x
24. Noebels, J. (2011). A perfect storm: converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia (Suppl. 1), 39-46. doi: 10.1111/j.1528-1167.2010.02909.x
25. Palop, J. J., and Mucke, L. (2009). Epilepsy and cognitive impairments in Alzheimer disease. Arch. Neurol. 66, 435-440. doi: 10.1001/archneurol.2009.15
26. Satchell, M. A., Zhang, X., Kochanek, P. M., Dixon, C. E., Jenkins, L. W., Melick, J., et al. (2003). A dual role for poly-ADP-ribosylation in spatial memory acquisition after traumatic brain injury in mice involving NAD+ depletion and ribosylation of 14-3-3gamma. J. Neurochem. 85, 697-708. doi: 10.1046/j.1471-4159.2003.01707.x
27. Sharma, P., Benford, B., Li, Z. Z., and Ling, G. S. (2009). Role of pyruvate dehydrogenase complex in traumatic brain injury and Measurement of pyruvate dehydrogenase enzyme by dipstick test. J. Emerg. Trauma Shock 2, 67-72. doi: 10.4103/0974-2700.50739
28. Shetty, P. K., Sadgrove, M. P., Galeffi, F., and Turner, D. A. (2012). Pyruvate incubation enhances glycogen stores and sustains neuronal function during subsequent glucose deprivation. Neurobiol. Dis. 45, 177-187. doi: 10.1016/j.nbd.2011.08.002
29. Simeone, K. A., Matthews, S. A., Samson, K. K., and Simeone, T. A. (2014). Targeting deficiencies in mitochondrial respiratory complex I and functional uncoupling exerts anti-seizure effects in a genetic model of temporal lobe epilepsy and in a model of acute temporal lobe seizures. Exp. Neurol. 251, 84-90. doi: 10.1016/j.expneurol.2013.11.005
30. Smith, J. A., Park, S., Krause, J. S., and Banik, N. L. (2013). Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration. Neurochem. Int. 62, 764-775. doi: 10.1016/j.neuint.2013.02.013
31. Stein, L. R., and Imai, S. (2012). The dynamic regulation of NAD metabolism in mitochondria. Trends Endocrinol. Metab. 23, 420-428. doi: 10.1016/j.tem.2012.06.005
32. Suh, S. W., Aoyama, K., Chen, Y., Garnier, P., Matsumori, Y., Gum, E., et al. (2003). Hypoglycemic neuronal death and cognitive impairment are prevented by poly(ADP-ribose) polymerase inhibitors administered after hypoglycemia. J. Neurosci. 23, 10681-10690.
33. Suh, S. W., Aoyama, K., Matsumori, Y., Liu, J., and Swanson, R. A. (2005). Pyruvate administered after severe hypoglycemia reduces neuronal death and cognitive impairment. Diabetes 54, 1452-1458. doi: 10.2337/diabetes.54.5.1452
34. Teichberg, V. I., Cohen-Kashi-Malina, K., Cooper, I., and Zlotnik, A. (2009). Homeostasis of glutamate in brain fluids: an accelerated brain-to-blood efflux of excess glutamate is produced by blood glutamate scavenging and offers protection from neuropathologies. Neuroscience 158, 301-308. doi: 10.1016/j.neuroscience.2008.02.075
35. Waldbaum, S., and Patel, M. (2010). Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Res. 88, 23-45. doi: 10.1016/j.eplepsyres.2009.09.020
36. Wang, Y., and Qin, Z. H. (2010). Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402. doi: 10.1007/s10495-010-0481-0
37. Ying, W., Chen, Y., Alano, C. C., and Swanson, R. A. (2002). Tricarboxylic acid cycle substrates prevent PARP-mediated death of neurons and astrocytes. J. Cereb. Blood Flow Metab. 22, 774-779. doi: 10.1097/00004647-200207000-00002
38. Zilberter, M., Ivanov, A., Ziyatdinova, S., Mukhtarov, M., Malkov, A., Alpar, A., et al. (2013). Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. J. Neurochem. 125, 157-171. doi: 10.1111/jnc.12127
39. Zlotnik, A., Gurevich, B., Cherniavsky, E., Tkachov, S., Matuzani-Ruban, A., Leon, A., et al. (2008). The contribution of the blood glutamate scavenging activity of pyruvate to its neuroprotective properties in a rat model of closed head injury. Neurochem. Res. 33, 1044-1050. doi: 10.1007/s11064-007-9548-x
40. Zlotnik, A., Sinelnikov, I., Gruenbaum, B. F., Gruenbaum, S. E., Dubilet, M., Dubilet, E., et al. (2012). Effect of glutamate and blood glutamate scavengers oxaloacetate and pyruvate on neurological outcome and pathohistology of the hippocampus after traumatic brain injury in rats. Anesthesiology 116, 73-83. doi: 10.1097/ALN.0b013e31823d7731